Theme 4 In vivo experimental models

Acknowledgments:

This work was supported by the Motor Neuron Disease Research Institute of Australia (MNDRIA; GIA 1827), the National Health and Medical Research Council of Australia (APP1034816 and Dementia Teams Grant 1095215), The Snow Foundation and MQ Safety Net Scheme.

Acknowledgments:

This project is supported by ALS 
Canada.

Acknowledgments:

We thank Christine V. Möser and Ellen Niederberger (Pharmazentrum Frankfurt/ZAFES, Institut für Klinische Pharmakologie, Klinikum der Goethe-Universität Frankfurt) for sharing of mice and protocols. This work was funded by the “Baustein-Programm” of the medical faculty of the University of Ulm. The authors declare no competing financial interests.

Acknowledgments:

This work was supported by grants from the German Federal Ministry of Education and Research (STRENGTH consortium and BMBF; 01GI0704), as well as a grant from the Frick Foundation for ALS research.

Acknowledgments:

We thanks to RIKEN RRC and Nagoya University CARE for support on animal experiments.

This project is mainly funded by Grants-in-Aid for Scientific Research from JSPS, Japan.

Acknowledgments:

Funding was provided by the NIH: R01 NS109150, R56 NS092572, RF1 AG057882-01, R01 NS110385, and R00 NS091486), the Robert Packard Center for ALS Research, and the Farber Family Foundation. The authors declare no conflicts of interest.

Acknowledgments:

This work was supported by the Motor Neurone Disease Research Institute Australia [2017 Betty Laidlaw Prize] and the Tasmanian Masonic Medical Research Foundation.

Acknowledgments:

We thank Motor Neuron Disease Research Institute of Australia, the Snow Foundation and philanthropic donations to Macquarie University for their ongoing support. The authors declare no conflicts of interest.

Acknowledgments:

Funding was generously provided by the Stuart Nichols ALS Research Foundation.

Acknowledgments:

Funding for this study was provided by NHMRC and MNDRIA. The authors declare no conflicts of interest.

Acknowledgments:

Funding was provided by ALS Canada and FRQS. The authors declare no conflicts of interest.

Acknowledgments:

Funded by MNDRIA, Snow Foundation and donations to Macquarie University.

Acknowledgments:

This study was financed by grants from Association Française contre les Myopathies (AFM), Agence Nationale pour la Recherche (ANR) (ERANET Neuron iPSoALS, CoEN Pathfinder 3035) and Aix-Marseille University to G. Haase. Imaging equipment at the UCSD School of Medicine Microscopy Core was funded by NINDS Grant P30 NS047101 and supported by J. Santini and M. Erb. D. Buttigieg was supported by PhD fellowships from Fondation pour la Recherche Médicale (FRM), AFM and ANR. The authors declare that they have no conflict of interest.

Acknowledgments:

Supported by grants from the Italian Ministry of Education, University and Research (PRIN project No. 2016058401 to GB and SIR project n. RBSI14B1Z1 to MM)

Acknowledgments:

This work was supported by grants from National Health and Medical Research Council (1044007) and Motor Neurone Disease Research Institute Australia (GIA 1704) to KB.

Acknowledgments:

Funding for this study was provided by NHMRC and MNDRIA. The authors declare no conflicts of interest.

Acknowledgments:

Funded by ALS Canada/ Brain Canada

Acknowledgments:

This study was supported by the Swedish Research Council, the Knut and Alice Wallenbergs foundation, the Bertil Hållsten foundation, the Torsten and Ragnar Söderbergh foundation, the Swedish Brain Fund, the Stratneuro initiative, the Västerbotten region and the Kempe foundation.

Acknowledgments:

Wellcome Trust Senior Investigator Award (GS; 107116/Z/15/Z), MRC Career Development Award (JNS: MR/S006990/1), Human Frontier Science Program Long-Term Fellowship (SS; LT000220/2017-L) and Horserace Betting Levy Board (SDC)

Acknowledgments:

This work was funded by the Alma Grace Holt MND Research Grant and Grant-In-Aid Research Grant, Motor Neuron Disease Research Institute of Australia

Acknowledgments:

We would like to acknowledge Sigrid Juselius Foundation, NHMRC (GNT1061550), FightMND, the University of Melbourne and the Florey Institute of Neuroscience and Mental Health for funding this study. The authors declare no conflicts of interest.

Acknowledgments:

This work was supported by the Motor Neurone Disease Research Institute Australia [2017 Betty Laidlaw Prize] and the Tasmanian Masonic Research Foundation

Acknowledgments:

This project is joint-funded by the MRC and DRI.

Acknowledgments:

This work is supported by grants from The Estate of Luther Allyn Shourds Dean.

Acknowledgments:

Funding for this study was provided by MNDA and Peter Samuel Charitable Trust.

Acknowledgments:

This study was supported by the grant from JSPS KAKENHI grant No.19K18429.

Acknowledgments:

This work has been supported by MNDRIA, FightMND translational grant and Victorian Brain Bank Network.

Acknowledgments:

RHB is supported by the NIH Grants nos. NS097545, NS069669, the Muscular Dystrophy Association (352536), the Robert and Louise Schwab family, and the Cedars-Sinai ALS Research Fund. MEM is supported by T32 GM118288.

Acknowledgments:

King’s ARUK Network and the DRI

Acknowledgments:

MND Association

Acknowledgments:

This work was funded by the EU Joint Programme in Neurodegenerative Disease Research (Grant RNA-NEURO)

Acknowledgments:

Funds for this study were provided by Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone (FR), Association pour la recherche et le développement de 
moyens de lutte contre les maladies neurodégénératives (RW), André Combat la SLA (JPL), and Région Alsace (RW). The authors declare no conflicts of interest.